Cytosorbents Corp
Research Cytosorbents Corp (CTSO) on Bullrun: market cap USD 23.97M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCTSO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 23.97M
- Financial periodFY2025
- RevenueUSD 37.06M
- Revenue growth4.1%
- Net income-USD 8.20M
- Free cash flow-USD 12.54M
- Gross margin71.5%
Valuation Snapshot
latest market cap is USD 23.97M.
About Cytosorbents Corp
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally.
Frequently asked questions
What is Cytosorbents Corp's market cap?
Cytosorbents Corp's market capitalization is USD 23.97M.
What does Cytosorbents Corp do?
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally.